A pharmacokinetic and pharmacodynamic immunocompromised mouse model of the human tick-borne disease babesia microti
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210717
- Recipient
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,965,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Funding
-
- $982,500.00 Federal
- $982,500.00 Non-federal
- Place of performance
- Baltimore, MD 21218, USA
Award details come from USAspending.gov.
About this award
The Johns Hopkins University was awarded a $1,965,000 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 2022 through July 2025 to develop a pharmacokinetic and pharmacodynamic immunocompromised mouse model of the human tick-borne disease Babesia microti. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions for battlefield wounds and other priorities. This award will support Johns Hopkins University in conducting applied research over three years that could advance understanding and treatment of Babesia microti, a pathogen of concern for both military service members and civilians.
Quick answers
Who received award W81XWH2210717?
W81XWH2210717 was awarded to The Johns Hopkins University by Medical Command (Department of the Army) on July 15, 2022.
How much is award W81XWH2210717 worth?
$1,965,000 has been obligated on W81XWH2210717: $982,500 in federal funding and $982,500 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award